CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunotherapy

The companies hosted a joint webcast on May 23, 2023, to discuss the transaction.

Morphogenesis Website

Be Part of a Powerhouse Team

We would love to see if you are a good fit for the CohBar Team. Look through our available positions or send us your resume.

We’d Love to Hear from You

By clicking "submit" below, you accept CohBar’s Terms of Use and acknowledge its Privacy Policy applies.

This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.